Search
for
Sort by
Research 31–60 of 96
- Pharmacotherapy of alopecia areata
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Satoyoshi Syndrome: Difficult to find or treat?
- Neuroimaging Findings in Congenital Biotinidase Deficiency: A Case Report
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Amla: An ancient medicinal plant with wide-ranging properties
- Clinical Profile and Outcomes of Patients With Systemic Lupus Erythematosus
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Exploring the effects of wetting and free fatty acid deposition on an atomistic hair fiber surface model incorporating Keratin Associated Protein 5-1
- 公表学術論文等リスト 2018
- Natural Killer Group 2 Type D (NKG2D) Gene Polymorphism in Systemic Lupus Erythematosus-Suez Canal Region - Egypt
- Poster Abstracts
- Minireview: vitamin D receptor: new assignments for an already busy receptor. - eScholarship
- A case of systemic lupus erythematosus complicated with aortic regurgitation due to bacterial endocarditis
- Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Protein Kinase C δ Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation–Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
- CBL1‐CIPK26‐mediated phosphorylation enhances activity of the NADPH oxidase RBOHC, but is dispensable for root hair growth
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Atypical Protein Kinase C Isoform, aPKCλ, Is Essential for Maintaining Hair Follicle Stem Cell Quiescence
- WRKY transcription factors (TFs): Molecular switches to regulate drought, temperature, and salinity stresses in plants
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Stem cells in embryonic skin development
- Avaliação dos efeitos adversos clínicos e alterações laboratoriais em pacientes com acne vulgar tratados com isotretinoína oral